These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22124672)

  • 1. Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.
    Redrobe JP; Elster L; Frederiksen K; Bundgaard C; de Jong IE; Smith GP; Bruun AT; Larsen PH; Didriksen M
    Psychopharmacology (Berl); 2012 Jun; 221(3):451-68. PubMed ID: 22124672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
    Ballard TM; Knoflach F; Prinssen E; Borroni E; Vivian JA; Basile J; Gasser R; Moreau JL; Wettstein JG; Buettelmann B; Knust H; Thomas AW; Trube G; Hernandez MC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):207-23. PubMed ID: 18936916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
    Abdul-Monim Z; Neill JC; Reynolds GP
    J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
    Broberg BV; Glenthøj BY; Dias R; Larsen DB; Olsen CK
    Psychopharmacology (Berl); 2009 Nov; 206(4):631-40. PubMed ID: 19390843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative modulation of α₅ GABAA receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion.
    Timić Stamenić T; Joksimović S; Biawat P; Stanković T; Marković B; Cook JM; Savić MM
    J Psychopharmacol; 2015 Sep; 29(9):1013-24. PubMed ID: 26105958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.
    Amitai N; Kuczenski R; Behrens MM; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1422-31. PubMed ID: 21238466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
    Pedersen CS; Goetghebeur P; Dias R
    J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.
    Damgaard T; Plath N; Neill JC; Hansen SL
    Psychopharmacology (Berl); 2011 Mar; 214(2):403-13. PubMed ID: 20957350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
    Idris N; Neill J; Grayson B; Bang-Andersen B; Witten LM; Brennum LT; Arnt J
    Psychopharmacology (Berl); 2010 Jan; 208(1):23-36. PubMed ID: 19851757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.
    Richetto J; Labouesse MA; Poe MM; Cook JM; Grace AA; Riva MA; Meyer U
    Int J Neuropsychopharmacol; 2015 Jan; 18(4):. PubMed ID: 25636893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
    Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
    Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study.
    Goetghebeur P; Dias R
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):287-93. PubMed ID: 18392753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.
    Roseman AS; McGregor C; Thornton JE
    Behav Brain Res; 2012 Jul; 233(1):105-12. PubMed ID: 22561127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RO4938581, a GABAAα5 modulator, displays strong CYP1A2 autoinduction properties in rats.
    Bundgaard C; Badolo L; Redrobe JP
    Biochem Pharmacol; 2013 May; 85(9):1363-9. PubMed ID: 23415905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome.
    Martínez-Cué C; Martínez P; Rueda N; Vidal R; García S; Vidal V; Corrales A; Montero JA; Pazos Á; Flórez J; Gasser R; Thomas AW; Honer M; Knoflach F; Trejo JL; Wettstein JG; Hernández MC
    J Neurosci; 2013 Feb; 33(9):3953-66. PubMed ID: 23447605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T; Sireeratawong S
    J Med Assoc Thai; 2013 Feb; 96(2):231-8. PubMed ID: 23936991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wannasiri S; Naowaboot J
    Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1234-1242. PubMed ID: 27562725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.